FOXO4-DRI inhibited SLE BM-MSC survival and induced apoptosis (normal cell death) more than 2 fold, suggesting that FOXO4-DRI can induce apoptosis of senescent SLE BM-MSCs
As we assist in a patients overall health, being mindful on centering the conversation on the health benefits of feeling stronger, more active, and meeting personal health metrics can get us to the goal of connecting the science with the art of medicine
Roche to present new obesity data at ADA 2026 Scientific Sessions Late-stage data highlight efficacy and safety of investigational therapies enicepatide and petrelintide for weight management 5 Jun 2026 Roche will present new Phase II data from its obesity portfolio, including the investigational medicines enicepatide (CT-388) and petrelintide, at the American Diabetes Association (ADA) 2026 Scientific Sessions in the United States
Vast majority of inflammatory autoimmune diseases can be controlled, however not completely cured
Certificate of Analysis Frequently Asked Questions This blend combines BPC-157 (a gastric pentadecapeptide) and TB-500 (a fragment of Thymosin Beta-4) in a single lyophilized formulation for tissue biology research